Skip to main content
Log in

Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute Inflammation

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Drug disposition is often altered in inflammatory disease. Although the influence of inflammation on hepatic drug metabolism and protein binding has been well studied, its impact on drug transport has largely been overlooked. The multidrug resistance (MDR) gene product, P-glycoprotein (P-gp) is involved in the active secretion of a large variety of drugs. Our goal was to ascertain the influence of acute inflammation (AI) on the expression and functional activity of P-gp.

Methods. AI was induced in rats through turpentine or lipopolysaccharide (LPS) administration. Expression of P-gp in liver was detected at the level of protein on Western blots using the monoclonal antibody C-219 and at the level of mRNA using an RNase protection assay. P-gp mediated transport activity was assessed by measuring the verapamil-inhibitable efflux of rhodamine 123 (R123) in freshly isolated hepatocytes.

Results. Turpentine-induced AI significantly decreased the hepatic protein expression of P-gp isoforms by 50−70% and caused a significant 45−65% reduction in the P-gp mediated efflux of R123. Diminished mRNA levels of all three MDR isoforms were seen. LPS-induced AI similarly resulted in significantly reduced levels and activity of P-gp in liver. Although differences in the constitutive levels of P-gp were seen between male and female rats, the influence of AI on P-gp expression and activity was not gender specific.

Conclusions. Experimentally-induced inflammation decreases the in vivo expression and activity of P-gp in liver. This is the first evidence that expression of P-gp is modulated in response to experimentally-induced inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. E. Schneider, J. Babb, H. Bishop, and M. Mitchard. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br. Med. J. 2:794–795 (1976).

    PubMed  Google Scholar 

  2. F. M. Belpaire, F. De Smet, B. Chindavijak, N. Fraeyman, and M. G. Bogaert. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fund. Clin. Pharmacol. 3:79–88 (1989).

    Google Scholar 

  3. M. Piquette-Miller and F. Jamali. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats. Pharm. Res. 10:294–299 (1993).

    PubMed  Google Scholar 

  4. Acute Phase Proteins: molecular biology, biochemistry & clinical Applications (A. Mackiewicz & I. Krushner, eds.), CRC Press Inc., Boca Raton, (1993).

    Google Scholar 

  5. E. T. Morgan. Suppression of constitutive P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36:699–707 (1989).

    PubMed  Google Scholar 

  6. K. A. Walker, H. Barber, and G. Hanksworth. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metab. Dispos. 14:482–486 (1986).

    PubMed  Google Scholar 

  7. S. E. Kane, I. Pastan, and M. M. Gottesman. Mini-review: genetic basis of multidrug resistance of tumor cells. J. Bioenerg. Biomem. 22:593–618 (1990).

    Google Scholar 

  8. P. F. Juranka, R. L. Zastawny, and V. Ling. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB. 3:2583–92 (1989).

    PubMed  Google Scholar 

  9. J. J. M. Smit, A. H. Schninkel, R. P. Elferink et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462 (1993).

    Article  PubMed  Google Scholar 

  10. T. W. Gant, J. A. Silverman, H. C. Bisgaard, R. K. Burt, P. A. Marino, and S. S. Thorgeirsson. Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450 1A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcin. 4:499–59 (1991).

    Google Scholar 

  11. K. V. Chin, S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265:221–226 (1990).

    PubMed  Google Scholar 

  12. B. T. Hill, K. L. Deuchars, L. K. Hosking, V. Ling, and R. D. Whelan. Overexpression of P-glycoprotein in mammalian tumor cells lines after fractionated X irradiation in vitro. J. Natl. Cancer Inst. 82:607–612 (1990).

    PubMed  Google Scholar 

  13. G. Schreiber, A. R. Aldred, T. Thomas et al. Levels of mRNA for plasma proteins in rat liver during acute experimental inflammation. Inflammation 10:59–67 (1986).

    PubMed  Google Scholar 

  14. J. Milland, A. Tsykin, T. Thomas, A. R. Aldred, T. Cole, and G. Schreiber. Gene expression in regenerating and acute-phase rat liver. Am. J. Physiol. 259:G340–7 (1990).

    PubMed  Google Scholar 

  15. G. Fantuzzi and C. A. Dinarello. The inflammatory response in IL-1-β-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukocyte Biol. 59:489–93 (1996).

    PubMed  Google Scholar 

  16. P. Moldeus, J. Hogberg, and S. Orrenius. Isolation and use of liver cells. Methods Enzymol. 52:60–70 (1978).

    PubMed  Google Scholar 

  17. P. C. Brown, S. S. Thorgeirsson, and J. A. Silverman. Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res. 21:3885–91 (1993).

    PubMed  Google Scholar 

  18. E. Chieli, E. Santoni Rugiu, F. Cervelli, A. Paolicchi, and R. Tongiani. Assessment of P-glycoprotein dependent drug transport in isolated rat hepatocytes using rhodamine 123. Cell Biol. Toxicol. 9:235–42 (1993).

    PubMed  Google Scholar 

  19. A. H. Schinkel, U. Mayer, E. Wagenaar et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94:4028–33 (1997).

    PubMed  Google Scholar 

  20. E. T. Morgan, K. B. Thomas, R. Swanson, T. Vales, J. Hwang, and K. Wright. Selective suppression of cytochrome P450 gene expression by IL-1 and IL-6 in rat liver. Biochim. Biophys. Acta 1219:475–483 (1994).

    PubMed  Google Scholar 

  21. M. Trauner, M. Arrese, C. J. Soroka et al. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroent. 113:255–264 (1997).

    Google Scholar 

  22. H-D. Flad, H. Loppnow, E. T. Rietschel, and A. J. Ulmer. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiol. 187:303–316 (1993).

    Google Scholar 

  23. W. Walther and U. Stein. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol. 120:471–478 (1994).

    PubMed  Google Scholar 

  24. N. J. Combates, R. W. Rzepka, Y. N. P. Chen, and D. Cohen. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human mdr1 gene promoter. J.Biol. Chem. 269:29715–9 (1994).

    PubMed  Google Scholar 

  25. J. J. M. Smit, C. A. Mol, L. Van Deemter, E. Wagenaar, A. H. Schninkel, and P. Borst. Characterization of the promoter region of the human MDR3 P-glycoprotein gene. Biochim. Biophys. Acta. 1261:44–56 (1995).

    PubMed  Google Scholar 

  26. C. H. Lee, G. Bradley, and V. Ling. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth & Differentiation 6:347–54 (1995).

    Google Scholar 

  27. J. Drach, A. Gsur, G. Hamilton et al. Involvement of P-gp in the transmembrane transport of IL-2, IL-4 and IFN-γ in normal human T-lymphocytes. Blood 88:1747–54 (1996).

    PubMed  Google Scholar 

  28. E. G. Schuetz, W. T. Beck, and J. D. Schuetz. Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately upregulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311–318 (1996).

    PubMed  Google Scholar 

  29. K. N. Furuya, R. Gebhardt, E. G. Schuetz, and J. D. Schuetz. Isolation of rat p-glycoprotein3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim. Biophys. Acta. 1219:636–644 (1994).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piquette-Miller, M., Pak, A., Kim, H. et al. Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute Inflammation. Pharm Res 15, 706–711 (1998). https://doi.org/10.1023/A:1011962818051

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011962818051

Navigation